| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 33.12M | 30.15M | 38.38M | 73.16M | 68.35M |
| Gross Profit | 16.23M | 12.42M | 11.23M | 41.24M | 41.66M |
| EBITDA | -15.56M | -16.66M | -38.02M | -82.12M | -28.30M |
| Net Income | -5.54M | -34.60M | -23.28M | -82.47M | -40.14M |
Balance Sheet | |||||
| Total Assets | 401.25M | 323.13M | 378.95M | 427.19M | 492.23M |
| Cash, Cash Equivalents and Short-Term Investments | 169.71M | 93.60M | 110.11M | 118.29M | 84.24M |
| Total Debt | 28.03M | 39.85M | 33.87M | 40.21M | 13.92M |
| Total Liabilities | 178.57M | 167.71M | 197.50M | 221.60M | 235.52M |
| Stockholders Equity | 257.47M | 175.19M | 207.27M | 217.50M | 262.11M |
Cash Flow | |||||
| Free Cash Flow | -23.88M | 22.95M | -33.21M | -7.83M | -22.85M |
| Operating Cash Flow | -23.27M | 23.04M | -33.21M | -7.81M | -20.00M |
| Investing Cash Flow | 10.49M | -2.52M | -353.00K | -3.82M | -13.34M |
| Financing Cash Flow | 17.96M | -43.23M | -9.56M | 72.88M | 1.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$2.90B | 6.49 | 16.02% | 6.09% | 13.92% | 21.08% | |
63 Neutral | HK$16.87B | 28.60 | 27.25% | ― | 33.17% | 152.01% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | HK$1.15B | 412.62 | 5.37% | ― | 37.70% | ― | |
48 Neutral | HK$3.01B | -34.65 | -23.25% | ― | 106.79% | -93.86% | |
47 Neutral | HK$850.83M | -125.93 | -2.57% | ― | 9.84% | 86.09% | |
39 Underperform | HK$272.55M | -4.08 | ― | ― | -14.23% | ― |